Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2
- PMID: 9724791
- PMCID: PMC27982
- DOI: 10.1073/pnas.95.18.10836
Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2
Abstract
A series of nonpeptide somatostatin agonists which bind selectively and with high affinity to somatostatin receptor subtype 2 (sst2) have been synthesized. One of these compounds, L-054,522, binds to human sst2 with an apparent dissociation constant of 0.01 nM and at least 3,000-fold selectivity when evaluated against the other somatostatin receptors. L-054,522 is a full agonist based on its inhibition of forskolin-stimulated adenylate cyclase activity in Chinese hamster ovary-K1 cells stably expressing sst2. L-054,522 has a potent inhibitory effect on growth hormone release from rat primary pituitary cells and glucagon release from isolated mouse pancreatic islets. Intravenous infusion of L-054,522 to rats at 50 microgram/kg per hr causes a rapid and sustained reduction in growth hormone to basal levels. The high potency and selectivity of L-054, 522 for sst2 will make it a useful tool to further characterize the physiological functions of this receptor subtype.
Figures






References
-
- Epelbaum J. Prog Neurobiol. 1986;27:63–100. - PubMed
-
- Raynor K, Reisine T. Crit Rev Neurobiol. 1992;16:273–289. - PubMed
-
- Reichlin S. N Engl J Med. 1983;309:1495–1503. - PubMed
-
- Brazeau P, Vale W, Burgus R, Ling N, Rivier J, Guillemin R. Science. 1972;129:77–79. - PubMed
-
- Pradayrol L, Jornvall H, Mutt V, Ribet A. FEBS Lett. 1980;109:55–58. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases